GV (Google Ventures) Activity
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Essay
Published an essay on how high-EQ founders manage organizational chaos while scaling.
Leading Under Pressure: How High-EQ Founders Manage the Chaos of Scale
Portfolio company Obsidian Therapeutics completed its merger with Galera Therapeutics and began trading on Nasdaq under ticker OBX.
Essay
Published a thesis essay arguing multimodal AI is replacing app-based navigation paradigms.
The End of Uniform Computing
Investment
Led Nebex's $30M seed round to build financial infrastructure for the commercial space economy.
Nebex
Exit
Portfolio company Modular signed a definitive agreement to be acquired by Qualcomm.
Modular
Exit
Portfolio company Parabilis Medicines went public in a record $670M+ biotech IPO on Nasdaq (PBLS).
Parabilis Medicines
Essay
Published an essay on the shift toward participatory software design.
The Age of Participatory Software
Investment
Led MokN's $15M Series A for its Phish-Back active identity recovery platform.
MokN
Essay
Published a thesis essay on the trajectory toward self-improving, recursively superintelligent AI systems.
Recursive Superintelligence
Investment
Co-led Sierra's Series E as the enterprise AI agent platform crossed $100M ARR.
Sierra
Essay
Published a thesis essay on Sierra AI and the era of enterprise AI agents.
Sierra: Giving the Enterprise a Voice
News
GV Europe celebrated investing more than $1 billion into European and Israeli startups, with 80% of new investments now in AI or AI-native companies.
GV Europe surpasses $1 billion invested across Europe and Israel
Investment
Led Synthesia's $200M Series E at $4B valuation, the largest round to date for the AI video platform.
Synthesia
Investment
Participated in Vercel's $300M Series F at $9.3B valuation as existing investor.
Vercel